Open Access DOI:10.23937/2643-4539/1710013
Part Two: Habit and Customs, Obesity and Parkinson's Disease
Muslimat Kehinde Adebisi, Li Xuezhong, Ehianeta Teddy and Liuyi
Article Type: Review Article | First Published: October 21, 2019
Keyword used in searching for similar articles on PubMed were, Obesity, hyperlipidemia, Metabolic syndrome (MetS), Neurodegenerative disorders, Parkinson’s diseases (PD). Papers from 2014-2019 related were compiled. Cases at Zhenjiang First people’s hospital similar was compiled to draw conclusions. I evaluated the association between years of diagnosis (YOD) of PD and BMI for both male and female patients and compared to controlled groups. There was a statistically significance between YOD ...
Open Access DOI:10.23937/2643-4539/1710012
Obesity may Increase the Prevalence of Parkinson’s Disease while Parkinson's may Reduce Obesity Index in Patients
Muslimat Kehinde Adebisi, Ehianeta Teddy, Mzee Said Abdulraman Salim, Liuyi, Abdul Nazif Mahmud, Aaron Gia Kanton and Abdullateef Taiye Mustapha
Article Type: Research Article | First Published: October 14, 2019
Currently Parkinson's disease is becoming more common among younger people of ages from 30-40 years. The incidence is higher among patients with higher BMI, some reports has it that Obesity is a risk factor for Parkinson’s disease while some reported that there is no relationship between obesity and Parkinson’s disease. Parkinson’s disease patient at the time of diagnosis has a above normal BMI but this goes below normal as the disease progresses. Therefore, it is important to explore the ...
Open Access DOI:10.23937/2643-4539/1710010
A Review on Alzheimer Disease
Deeksha Kaloni and Abhishek Negi
Article Type: Review Article | First Published: September 18, 2019
Alzheimer is one of the most common causes of dementia that influence nerve cells in various parts of the brain. Pathologically it is caused because of intracellular neurofibrillary tangles and extracellular amyloidal protein and results in the deposition of plaques which obstruct the communication between the nerve cells resulting in this neurodegenerative disease. The genetic risk factor found to be associated with this disease is mutation in APP, PSEN1 and PSEN2 genes. Also, the diet and nutr...
Open Access DOI:10.23937/2643-4539/1710009
Acute Cognitive Effects of Physical Activity for People who have Dementia
Jordan Elliott-King, Elizabeth Peel and Eef Hogervorst
Article Type: Original Article | First Published: August 01, 2019
Physical activity has the potential to improve cognition for those with dementia, as demonstrated by randomised controlled trials lasting at least 6 weeks. Research is yet to explore the acute cognitive effects of physical activity for people with dementia. Acute resistance physical activity with healthy late-middle aged individuals has been shown to facilitate general cognition, as well as benefit executive function specifically. This study therefore aimed to establish if people with dementia e...
Open Access DOI:10.23937/2643-4539/1710008
Parkinson's Disease, Diabetes, Functional Decline and Cognitive Impairment: A Comparative Study of Elderly Mexican Americans and Non-Hispanic Whites
Peter L Heller, PhD, David F Briones, MD, James A Wilcox, MD, PhD and Jose Manuel de la Rosa, MD
Article Type: Research Article | First Published: July 11, 2019
We report logistic regression analyses findings from a community sample of elderly Mexican Americans and non-Hispanic whites demonstrating that degrees of associations between diabetes and PD with CImp persist after controlling for effects of functional decline. However, after adding effects of a number of control variables (including ethnicity) to the equation, association between diabetes and CImp is no longer significant. We suggest that these findings may well be an artifact of the high prev...
Open Access DOI:10.23937/IJND-2017/1710007
Identification of PSEN1 and PSEN2 Gene Variants and Clinical Findings with the Literature
Nadide Cemre Randa, Elçin Bora, Esra Ataman, Ozlem Oz, Gorsev Yener and Ayfer Ulgenalp
Article Type: Original Article | First Published: April 11, 2019
Alzheimer's disease is an age-related and irreversible disease and characterized progressively decline in cognitive functions such as memory, speech, executive functions and visual-spatial skills. Currently, there is no a simple and definitive diagnosis method for clinical management. It is possible to diagnose with 85-90% accuracy with clinical assesment and neuropsychological tests. The precisely-known risk factors associated with Alzheimer's disease are aging, family history, and the presence...
